Navigation Links
Rigel to Present at BIO CEO & Investor Conference
Date:2/6/2008

SOUTH SAN FRANCISCO, Calif., Feb. 6 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to present a company overview at the BIO CEO & Investor Conference 2008 in New York on Monday, February 11 at 11:45 a.m. EST.

To access the live audio webcast or the subsequent archived recording, log on to http://www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

About Rigel (http://www.rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and metabolic diseases. Our goal is to file one new investigational new drug (IND) application in a significant indication each year. Rigel has achieved this goal every year since 2002. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.

Contact: Ryan Maynard

Phone: 650.624.1284

Email: invrel@rigel.com


'/>"/>
SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Rigel Announces Pricing of Public Offering of Common Stock
2. Rigel to Present Research Programs at Scientific Conferences
3. Rigel to Present at BIO Investor Forum 2007
4. Cell Therapeutics, Inc. (CTI) to Present at 10th Annual BIO CEO & Investor Conference
5. SGX Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
7. Memory Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
8. ViroPharma to Present at the BIO CEO & Investor Conference
9. Perrigo Company to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
10. MiddleBrook Pharmaceuticals to Present at BIO CEO & Investor Conference 2008
11. Celator(R) Pharmaceuticals to Present at 10th Annual BIO CEO and Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... tru Shrimp™ Systems announced today that ... University for the exclusive worldwide rights to commercialize Tidal ... The license agreement for the patented technology, developed by ... such as China, Taiwan, France, Germany, Italy, Spain, the ... had inquires from all over the world for our ...
(Date:4/27/2015)... April 27, 2015 Elsevier , ... and services, and Qatar University Research Office   have announced ... The awards ceremony, held last week at ... was attended by more than 40 guests representing ... presented by Professor Sheikha Abdulla Al-Misnad , President of ...
(Date:4/24/2015)... 24, 2015 The South Dakota School ... have entered into an agreement to promote cooperation on ... agreement signed by the universities will encourage and promote ... other services particularly, though not exclusively, relating to sustainability, ... strengths and a similar set of values,” said Michael ...
(Date:4/24/2015)... 24, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... the supplier of bio-succinic acid used to produce ... textile applications that Bayer MaterialScience has begun commercializing.  ... ® eco, a series of bio-based waterborne ... high as 65%.  IMPRANIL ® eco has ...
Breaking Biology Technology:tru Shrimp™ Systems Acquires Global Patent for Tidal Basin™ Shrimp Production 2Elsevier Announces the Winners of Qatar University Scientists 2015 Scopus Awards 2Elsevier Announces the Winners of Qatar University Scientists 2015 Scopus Awards 3Elsevier Announces the Winners of Qatar University Scientists 2015 Scopus Awards 4Elsevier Announces the Winners of Qatar University Scientists 2015 Scopus Awards 5South Dakota Mines, Arizona State University Pave Way for Cooperative Research 2Bayer MaterialScience Names BioAmber As Its Supplier For New Product Line - Bio-succinic acid forms backbone of innovative new bio-based polyurethanes for textiles 2Bayer MaterialScience Names BioAmber As Its Supplier For New Product Line - Bio-succinic acid forms backbone of innovative new bio-based polyurethanes for textiles 3Bayer MaterialScience Names BioAmber As Its Supplier For New Product Line - Bio-succinic acid forms backbone of innovative new bio-based polyurethanes for textiles 4
... , ... SmithKline Beecham Pharmaceuticals, UK , ... is a 96-well white polystyrene microplate with scintillant-coated wells designed for highvolume, ... platform for the measurement of G-protein activation by means of an assay ...
... INTRODUCTION , ... upon binding of an agonist, a transient increase in intracellular ... and is an important modulator of many physiological mechanisms (reviewed ... (1997)). Measurement of intracellular calcium concentration in cells expressing a ...
... Author: , Heidi Grecsek ... 710 Bridgeport Avenue , ... Introduction , The Clean ... produce fuel with increased oxygen content. Oxygenated fuel is desirable because it burns more ...
Cached Biology Technology:Use of FlashPlate Technology for In Vitro Measurement of [35S]-GTPγS Binding in CHO Cells Expressing the Human 5-HT1B Receptor 2Use of FlashPlate Technology for In Vitro Measurement of [35S]-GTPγS Binding in CHO Cells Expressing the Human 5-HT1B Receptor 3Use of FlashPlate Technology for In Vitro Measurement of [35S]-GTPγS Binding in CHO Cells Expressing the Human 5-HT1B Receptor 4Use of FlashPlate Technology for In Vitro Measurement of [35S]-GTPγS Binding in CHO Cells Expressing the Human 5-HT1B Receptor 5Cell lines expressing recombinant aequorin and a G-protein coupled receptor for functional screening 2Cell lines expressing recombinant aequorin and a G-protein coupled receptor for functional screening 3Cell lines expressing recombinant aequorin and a G-protein coupled receptor for functional screening 4Cell lines expressing recombinant aequorin and a G-protein coupled receptor for functional screening 5Cell lines expressing recombinant aequorin and a G-protein coupled receptor for functional screening 6Cell lines expressing recombinant aequorin and a G-protein coupled receptor for functional screening 7Cell lines expressing recombinant aequorin and a G-protein coupled receptor for functional screening 8Analysis of Fuel Oxygenates by U.S. EPA Method 8260B Using Headspace Trap with GC/MS 2Analysis of Fuel Oxygenates by U.S. EPA Method 8260B Using Headspace Trap with GC/MS 3Analysis of Fuel Oxygenates by U.S. EPA Method 8260B Using Headspace Trap with GC/MS 4
(Date:4/2/2015)... 2015 Fingerprint Cards (FPC) has ... from the distributor World Peace Industrial Group (WPI), part ... although the major part of the shipments will take ... by smartphone manufacturers in China . ... the communicated revenue guidance of + 1 000 MSEK for ...
(Date:3/31/2015)... NEW YORK , March 31, 2015   ... announced the launch of the Post-Surgical Pain Management TRACKER, ... data products tracking usage trends in the medical device ... monthly access to data including treatment volumes, market share, ... manage the pain associated with joint surgery. ...
(Date:3/24/2015)... and Markets ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ) has announced the addition ... Report" report to their offering. This report analyzes ... by the following Segments: Face Biometrics, and Voice Biometrics. The report ... , Japan , Europe , ... & Africa , and Latin America ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6
... molecule which can stop the formation of long protein ... in kidney dialysis patients has been identified by researchers ... lead to new methods to identify drugs to prevent, ... which amyloid fibrils play a part, including Alzheimer,s, Parkinson,s ...
... scientists have long debated whether all cells within a tumour ... - a question that has been highly investigated in experimental ... Nature Medicine (10.1038/nm.2415) focuses on patients and shows that ... properties, called leukemia stem cells (LSC), that are better at ...
... The role of national governments in ecological ... While scientists and campaigners alike often demand that ... and conflicts with land owners or corporations makes ... Ecology reports, Brazil is one of a handful ...
Cached Biology News:Research offers new way to target shape-shifting proteins 2New research validates clinical importance of leukemia stem cells 2